These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 24947770

  • 1. Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants.
    Del Ben M, Polimeni L, Brancorsini M, Di Costanzo A, D'Erasmo L, Baratta F, Loffredo L, Pastori D, Pignatelli P, Violi F, Arca M, Angelico F.
    Eur J Intern Med; 2014 Jul; 25(6):566-70. PubMed ID: 24947770
    [Abstract] [Full Text] [Related]

  • 2. Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome.
    Stättermayer AF, Traussnigg S, Aigner E, Kienbacher C, Huber-Schönauer U, Steindl-Munda P, Stadlmayr A, Wrba F, Trauner M, Datz C, Ferenci P.
    J Trace Elem Med Biol; 2017 Jan; 39():100-107. PubMed ID: 27908400
    [Abstract] [Full Text] [Related]

  • 3. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
    Donati B, Motta BM, Pingitore P, Meroni M, Pietrelli A, Alisi A, Petta S, Xing C, Dongiovanni P, del Menico B, Rametta R, Mancina RM, Badiali S, Fracanzani AL, Craxì A, Fargion S, Nobili V, Romeo S, Valenti L.
    Hepatology; 2016 Mar; 63(3):787-98. PubMed ID: 26605757
    [Abstract] [Full Text] [Related]

  • 4. Association of metabolic syndrome and patatin-like phospholipase 3 - rs738409 gene variant in non-alcoholic fatty liver disease among a Chennai-based south Indian population.
    Narayanasamy K, Karthick R, Panneerselvam P, Mohan N, Ramachandran A, Prakash R, Rajaram M.
    J Gene Med; 2020 Apr; 22(4):e3160. PubMed ID: 31945251
    [Abstract] [Full Text] [Related]

  • 5. I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders.
    Xia MF, Ling Y, Bian H, Lin HD, Yan HM, Chang XX, Li XM, Ma H, Wang D, Zhang LS, Wang SS, Wu BJ, He WY, Zhao NQ, Gao X.
    Aliment Pharmacol Ther; 2016 Mar; 43(5):631-42. PubMed ID: 26765961
    [Abstract] [Full Text] [Related]

  • 6. I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease.
    Park JH, Cho B, Kwon H, Prilutsky D, Yun JM, Choi HC, Hwang KB, Lee IH, Kim JI, Kong SW.
    Liver Int; 2015 Dec; 35(12):2537-46. PubMed ID: 26148225
    [Abstract] [Full Text] [Related]

  • 7. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.
    Luukkonen PK, Zhou Y, Sädevirta S, Leivonen M, Arola J, Orešič M, Hyötyläinen T, Yki-Järvinen H.
    J Hepatol; 2016 May; 64(5):1167-1175. PubMed ID: 26780287
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.
    Wang CW, Lin HY, Shin SJ, Yu ML, Lin ZY, Dai CY, Huang JF, Chen SC, Li SS, Chuang WL.
    Liver Int; 2011 Oct; 31(9):1326-31. PubMed ID: 21745282
    [Abstract] [Full Text] [Related]

  • 11. Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial.
    Scorletti E, West AL, Bhatia L, Hoile SP, McCormick KG, Burdge GC, Lillycrop KA, Clough GF, Calder PC, Byrne CD.
    J Hepatol; 2015 Dec; 63(6):1476-83. PubMed ID: 26272871
    [Abstract] [Full Text] [Related]

  • 12. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Tai CM, Huang CK, Tu HP, Hwang JC, Chang CY, Yu ML.
    Surg Obes Relat Dis; 2015 Dec; 11(4):888-94. PubMed ID: 25240529
    [Abstract] [Full Text] [Related]

  • 13. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
    Krawczyk M, Jiménez-Agüero R, Alustiza JM, Emparanza JI, Perugorria MJ, Bujanda L, Lammert F, Banales JM.
    Surg Obes Relat Dis; 2016 Dec; 12(10):1838-1846. PubMed ID: 27576208
    [Abstract] [Full Text] [Related]

  • 14. PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
    Aragonès G, Auguet T, Armengol S, Berlanga A, Guiu-Jurado E, Aguilar C, Martínez S, Sabench F, Porras JA, Ruiz MD, Hernández M, Sirvent JJ, Del Castillo D, Richart C.
    Int J Mol Sci; 2016 Apr 27; 17(5):. PubMed ID: 27128907
    [Abstract] [Full Text] [Related]

  • 15. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.
    Chen LZ, Xin YN, Geng N, Jiang M, Zhang DD, Xuan SY.
    World J Gastroenterol; 2015 Jan 21; 21(3):794-802. PubMed ID: 25624712
    [Abstract] [Full Text] [Related]

  • 16. Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents.
    Mosca A, Fintini D, Scorletti E, Cappa M, Paone L, Zicari AM, Nobili V, Byrne CD.
    Liver Int; 2018 Dec 21; 38(12):2301-2308. PubMed ID: 30176114
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population.
    Verrijken A, Beckers S, Francque S, Hilden H, Caron S, Zegers D, Ruppert M, Hubens G, Van Marck E, Michielsen P, Staels B, Taskinen MR, Van Hul W, Van Gaal L.
    Obesity (Silver Spring); 2013 Oct 21; 21(10):2138-45. PubMed ID: 23512881
    [Abstract] [Full Text] [Related]

  • 19. Correlations between PNPLA3 Gene Polymorphisms and NAFLD in Type 2 Diabetic Patients.
    Gavril OI, Arhire LI, Gavril RS, Zota MI, Gherasim A, Nita O, Drugescu A, Oprescu AC, Esanu IM, Mitu F, Graur M, Mihalache L.
    Medicina (Kaunas); 2021 Nov 15; 57(11):. PubMed ID: 34833467
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.